Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of Novocell (now Vertex), a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases.Novocell has several CIRM grants to develop a stem cell-based ...

View post:

Stem Cell and Genetic Research CIRM

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh